Responsible Person v. Safety Assessor Sylvie Gallage-Alwis Avocat à la Cour / Solicitor in England & Wales ECORE ERPA Seminar – Tel Aviv – 16 June 2014.

Slides:



Advertisements
Similar presentations
19 April 2012 The Office Agents Society Changes of Use from Commercial To Residential Michael Gallimore Hogan Lovells International LLP.
Advertisements

Art. 6 – 8 of the draft Unitary Patent Regulation Prof. Dr. Winfried Tilmann.
The Telephone Consumer Protection Act: New Developments and Issues to Watch September 26, 2014 Mark W. Brennan, Partner.
February 12, 2014 Life Sciences Enforcement Year in Review: Examining Hot Button Areas for FDA & Related Government Enforcement Peter Spivack, Hogan Lovells.
7 March 2014 International Arbitration, Paris 20 Years of the Energy Charter Treaty Jurisdiction and Admissibility under the Energy Charter Treaty Laurent.
2005 Auckland Berlin Beijing Bratislava Brussels Budapest Chicago Copenhagen The Hague Dublin Helsinki Ho Chi Minh City Istanbul Johannesburg London Lisbon.
October 18, 2011 Device Development in Obesity and Metabolic Disease (DDOMD) Workshop Regulatory Considerations in Device Development Jonathan S. Kahan,
Wireless Access Code: Download the agenda PDF at:
16 July 2011 The Business Case for Mediation (for “ICC Arbitration & Amicable Dispute Resolution – Focus on India”) Jonathan Leach, partner, Hogan Lovells.
Product Recalls and Reporting Obligations in Europe Presentation to ICPHSO Asia-Pacific Symposium Seoul, Korea, 31 October to 2 November 2011 Rod Freeman.
April 8, 2013 NPE litigation in Japan Activities and impact of FRAND commitments Eiichiro Kubota, Hogan Lovells Tokyo.
S4: Market Surveillance Physikalisch-Technische Bundesanstalt Session 4: Market surveillance Peter Ulbig, Harry Stolz Belgrade, 31 October.
Health and Consumers Health and Consumers 1 Commission’s expectations to MS’ structures of enforcement Enforcement of European Animal Welfare related legislation.
Mr. Doram Elkayam – Obelis s.a. Chief Operations Officer
Hogan Lovells EU Product Safety and Market Surveillance Reforms How will this impact businesses – Lawyers' view BIICL seminar, 2 October.
Understanding the GRAS Process Martin J. Hahn Hogan Lovells US LLP Date: July 16, 2013 Food and Agriculture Group.
© Allen & Overy 2013 Global reach and local depth – your perfect match Luxembourg-Russia Desk Jacques Wantz In charge of the Luxembourg-Russia Desk Allen.
LLP The Commission's State aid policy and the current financial crisis GCLC lunch talk - 20 February 2009 Jacques Derenne Partner.
January 2012 Workshop on competition law aspects International Legal Expert Meeting, January 2012 Leiden University, The Netherlands Jacques Derenne.
Recent developments in aviation liability & insurance: The 1973 Hague Convention on the law applicable to products liability: choice of law issues in aviation.
January 29-30, 2013 Tokyo, Japan Exportation of Knock-Down Kits: (Direct or Indirect) Infringement? AIPLA Mid-Winter 2013 Pre-Meeting Yusuke Inui, Attorney.
"The Role of Arbitration in the Dispensal of Justice" Does Arbitration Maintain the Advantages it Traditionally Enjoyed? Nathan Searle, Senior Associate.
© 2009 Hogan & Hartson LLP. All rights reserved. Joseph A. Levitt Hogan & Hartson April 21, 2009 FDA Regulation of Bottled Water An Overview.
Erik Hansson DG Health and Consumer Protection (DG SANCO) European Commission Developments on product safety in the EU.
Unfulfilled Promises: Affordable Housing in Metropolitan Washington Presentation to the Metropolitan Washington Council of Governments Mary Anne Sullivan,
Recent Developments and New Challenges Under the Telephone Consumer Protection Act NCHER Winter Legal Meeting Mark W. Brennan January 24, 2014.
Food Safety Modernization Act: Are You Ready? March 27, 2012 Gary Jay Kushner NPA Annual Meeting La Playa, Florida.
Ethical Issues in Setting Litigation Reserves Clay James, Partner at Hogan Lovells Annie Kao, Senior Litigation Counsel at Vail Resorts December 8, 2010.
Defense Trade Regulatory Requirements & National Security Reviews of Foreign Investment in the United States Presentation to IACC Aerospace, Defense &
Nicolas Pourbaix, Senior Associate
January 25, 2012 Regulatory Update Report to NCC Marketing Committee Robert O. Winters.
January 2012 Workshop on Radio Frequencies International Legal Expert Meeting, January 2012 Leiden University, The Netherlands Gerry Oberst.
Protection of Intellectual Property in the Customs Union of Russia, Belarus and Kazakhstan By Natalia Gulyaeva.
27 October 2011 Competitive dialogue in UK PFI PPP Forum Perspective Andrew Briggs, Partner.
December 8, 2014 Healthcare/Privacy Current Law Affecting Uses of Health Data Melissa Bianchi Partner.
Hogan Lovells The solicitor's role Gathering the evidence –Disclosure in most cases: –Disclosure in most fraud cases: 1.
27 September 2013 Promoting Russia as a Seat of Arbitration: What Are the Best Ways Forward? Peter Pettibone.
Project co-financed by European Union Project co- financed by Asean European Committee for Standardization Implementing Agency 1 Module 13 GMP Workshop.
SEMINAR on the EEA Financial Mechanism THE EUROPEAN COMMISSION DIRECTORATE- GENERAL REGIONAL POLICY Brussels 13 June 2005 Control and Audit Nicholas Martyn.
Overview of the EU Food Safety Requirements
Support for the Modernisation of the Mongolian Standardisation system – EuropeAid/134305/C/SER/MN Training on standardisation Support to the Modernisation.
© Hogan & Hartson LLP. All rights reserved. Clinical Trials Track: Key Compliance Risks FDA Overview Meredith Manning November 8, 2007.
© Siemens AG 2014 Alle Rechte vorbehalten.siemens.com/lowvoltage New Legislative Framework (NLF) Sektor Infrastructure & Cities | Division Low and Medium.
The revised EU Cosmetics Legislation
S tefano S oro European Commission Health and Consumer Protection DG OBLIGATION OF PRODUCERS AND DISTRIBUTORS TO NOTIFY DANGEROUS PRODUCTS.
Mutuals' Forum 2010 Regulators & Legislators: Appreciating the Mutual Difference John Gilbert, Consultant 4 November 2010.
© Hogan & Hartson LLP. All rights reserved. National Pharma Audioconference Bristol-Myers Squibb 2007 Settlement Stephen J. Immelt, Esq. November 26, 2007.
Russian response to US sanctions: what has been done and what to expect? 14 August 2014.
November 2015 Presentation to South African Diamond Producers Organisation on Legal Liability Awareness – Introduction to the Mine Health & Safety Act.
Directorate General for Enterprise and Industry European Commission The New Legislative Framework - Market Surveillance UNECE “MARS” Group meeting Bratislava,
Support for the Modernisation of the Mongolian Standardisation system – EuropeAid/134305/C/SER/MN Training on standardisation Support to the Modernisation.
© Hogan & Hartson LLP. All rights reserved. Catriona Hatton, Partner 26 May 2008 Medical Device Companies Antitrust Compliance Programmes.
Brian Lightfoot Cosmetics Europe
CE Marking as Related to CPR Regulation (EU) No 305/2011
Responsible person, Distributors Responsibilities & Obligations Non-compliance Irina T ă nase Toxicologist - National Institute of Public Health, Romania.
Turnaround Management Association of Southern Africa - presentation Panamo Properties (Pty) Ltd v Nel and Another NNO NUMSA v Wilro Supplies CC & Companies.
THE OFFICE FOR REGISTRATION OF MEDICINAL PRODUCTS, MEDICAL DEVICES AND BIOCIDAL PRODUCTS Responsibility in the handling of medical devices.
OUTLINE OF KEY PROVISIONS IN THE EU REGULATION (1223/2009) ON COSMETIC PRODUCTS INT MARKT Turkey, Ankara 2013 István Murányi KOZMOS, secretary-general.
The EU Cosmetics Regulation Matthew A. Kopetski Commercial Specialist U.S. Mission to the European Union February 21 st, 2013.
REGULATION (EC) Nº 1223/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 30 November 2009 on cosmetic products 1 Shall apply from 11.
6 October 2016 Social media: do you have the right social media strategy that will impact your business’ growth? - Legal and Regulatory Issues William.
TRACEABILITY REQUIREMENTS UNDER EU GENERAL FOOD LAW
The Mutual Recognition Regulation
FSMA Enforcement: Focus on Inspections
Single Firm Conduct: EU / US convergences and divergences
Hogan Lovells. Hogan Lovells TC Hogan Lovells.
Supply chain management
EU Food Safety Requirements: - Hygiene of Foodstuffs -
Presentation transcript:

Responsible Person v. Safety Assessor Sylvie Gallage-Alwis Avocat à la Cour / Solicitor in England & Wales ECORE ERPA Seminar – Tel Aviv – 16 June 2014

Overview Regulation 1223/2009 dated 30 November 2009 – fully into force since 11 July 2013 Responsible person: "Only cosmetic products for which a legal or natural person is designated within the Community as 'responsible person' shall be placed on the market" (Art. 4) Safety assessor:  "In order to demonstrate that a cosmetic product complies with Article 3, the responsible person shall, prior to placing a cosmetic product on the market, ensure that the cosmetic product has undergone a safety assessment" (Art. 10)  "a person in possession of a diploma or other evidence of formal qualifications awarded on completion of a university course of theoretical and practical study in pharmacy, toxicology, medicine or a similar discipline, or a course recognised as equivalent by a Member State" (Art. 10) 2

Responsible Person v. Safety Assessor 1.2 key players for 1 top priority in the EU: the protection of the consumers 2.The definition of the Responsible Person and the Safety Assessor 3.The Roles of the Responsible Person and the Safety Assessor 4.The liabilities and risks that may be faced by the Responsible Person and the Safety Assessor 5.The diverging interests of the Responsible Person and the Safety Assessor 6.The need for cooperation 3

1. Top priority in the EU : protection of the consumers Regulation 1223/ Article 1: "This Regulation establishes rules to be complied with by any cosmetic product made available on the market, in order to ensure the functioning of the internal market and a high level of protection of human health". 2 key players : the Responsible Person the Safety Assessor 4

2. Definition of the Responsible Person and the Safety Assessor Safety Assessor Article 10 of Regulation 1223/2009 "person in possession of a diploma or other evidence of formal qualifications awarded on completion of a university course of theoretical and practical study in pharmacy, toxicology, medicine or a similar discipline, or a course recognised as equivalent by a Member State" 5 Responsible Person (RP) Article 4 of Regulation 1223/2009 Cosmetic product manufactured within the EU, by a manufacturer established within the EU, not subsequently exported and imported back in the EU : -The manufacturer shall be the RP -The manufacturer may designate by written mandate, a person established within the EU Imported cosmetic products : -Each importer shall be the RP of the product he places on the market -The importer may designate by written mandate, a person established within the EU Cosmetic product manufactured within the EU, by a manufacturer established outside the EU, not subsequently exported and imported back in the EU : -The manufacturer must designate by written mandate, a person established within the EU Cosmetic product placed on the market under the distributor's name or trademark or product already placed on the market modified by the distributor in such a way that compliance with the applicable requirements may be affected : -The distributor shall be the RP 4 cases

3. Roles of the Responsible Person and the Safety Assessor 6 The Responsible Person: Ensures compliance of the product with the rules set out in the Regulation relating to:  Human health  Safety  Consumer information Maintains a product information file accessible to the public authorities Ensures product traceability by identifying the distributors to whom they supply the cosmetic product for a period of three years following the date on which the batch of the cosmetic product was made available to the distributor (the same applies to all other persons involved in the supply chain) In case of non-compliance with the Regulation, takes corrective measures, withdraws the product or recalls it Informs the authorities if the product presents a risk to human health The Safety Assessor: Carries out the cosmetic product safety assessment, as set out in Part B of Annex I of Regulation 1223/2009

List of the obligations of the Responsible Person Safety (article 3) Good manufacturing practices (article 8) Safety assessment (article 10) Product information file (article 11) Sampling and analysis (article 12) Notification (article 13) Restrictions for substances listed in the Annexes (article 14) CMR (article 15) Nanomaterials (article 16) Traces of prohibited substances (article 17) Animal testing (article 18) Labelling (article 19) Product claims (article 20) Access to information for the public (article 21) Communication of serious undesirable effects (article 23) Information on substances (article 24) 7

How do they both contribute to the protection of consumers? 8 Ensures safety of the product Ensures market surveillance Ensures transparency Ensures cooperation with the Authorities The Responsible Person Ensures safety of the product The Safety Assessor

4. Liabilities 9 Principle of liability of the Responsible Person Safety Assessor's unique expertise Share of liability between the Responsible Person and the Safety Assessor concerning the safety of the product

10 What are the risks? If the product does not comply with the Regulation or the good manufacturing practices → even if no safety risk If the product presents a safety risk Sanctions to be established by each Member State Civil liability Contractual liability Criminal liability

11 Article 10 of Regulation 1223/2009 Responsible Person is liable for Annex I Part A (Cosmetic Product Safety Report) 1.Quantitative and qualitative composition of the cosmetic product 2.Physical/chemical characteristics and stability of the cosmetic product 3.Microbiological quality 4.Impurities, traces, information about the packaging material 5.Normal and reasonably foreseeable use 6.Exposure to the cosmetic product 7.Exposure to the substances 8.Toxicological profile of the substances 9.Undesirable effects and serious undesirable effects 10.Information on the cosmetic product Safety Assessor is liable for Annex I Part B (Cosmetic Product Safety Assessment) 1.Assessment conclusion 2.Labelled warnings and instructions of use 3.Reasoning 4.Assessor's credentials and approval of part B Result type of obligation → as soon as there is a non- compliance, liability is incurred Best efforts type of obligation → the liability will be incurred if it is shown that not all the reasonably expected and necessary steps were taken

5. The diverging interests of the Responsible Person and the Safety Assessor 12 Safety Assessor Make sure it has all the appropriate data to carry out its mission Have its liability limited in case of non-compliance Be sure that the product will not change after its assessment Responsible Person Be 200% sure that the product is compliant with the Regulation Have all data necessary to be sure and answer the authorities Have its liability limited in case of non-compliance

13 Diverging interests = diverging clauses Responsible Person Limitation of liability clause Definition of the obligations of the Safety Assessor Involvement of the Safety Assessor in case of control/claim Information of the Safety Assessor in case it looses its diploma or has its liability at stake for another product Safety Assessor Detailed description of the assessed product Limitation of liability clause Definition of the information to be provided by the Responsible Person Amendment of the contract in case of further tests to be carried out Obligation of the Responsible Person to inform on any change in the product/formula

6. Cooperation between the Responsible Person and the Safety Assessor Diverging interests should not lead to a lack of cooperation Cooperation is needed:  to set up the cosmetic product safety report "Where the responsible person drawing up the cosmetic product safety report is not the manufacturer of the product, they should ensure they have access to all the technical and scientific skills necessary to obtain reliable cosmetic product safety information and an appropriate safety assessment to demonstrate that the product they are responsible for is safe […]. They may therefore need to involve […] the safety assessor" (Guidelines on Annex I to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products)  to ensure that the safety of the product is properly assessed "The responsible person and the safety assessor should work closely together to ensure that the safety of the product is properly assessed and documented and that the assessment is kept up to date. The responsible person and the safety assessor should gather all the necessary information as required by Part A of Annex I to Regulation (EC) No 1223/2009" (Guidelines on Annex I to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products) 14

Cooperation between the Safety Assessor and the Responsible Person  to ensure that the Safety Assessor has all the data needed for the safety assessment of the product "Part A of the cosmetic product safety report is intended to gather the data necessary to prove that the cosmetic product is safe. The information should enable the safety assessor to clearly identify and quantify, based on the identified hazards, the risks a cosmetic product may present to human health". "The responsible person, may consider that, depending on the type of product, some of the required data are not relevant or necessary to assess the safety of the product (e.g. preservation challenge test). In this case, the absence of specific data is to be clearly justified in Part A and the justification is to be repeated and validated by the safety assessor in their reasoning in Part B. The responsible person should check the presence of the required data or the justification for their absence". (Guidelines on Annex I to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products) 15

Questions 16 Contact: Sylvie Gallage-Alwis

"Hogan Lovells" or the "firm" is an international legal practice that includes Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses. The word "partner" is used to describe a partner or member of Hogan Lovells International LLP, Hogan Lovells US LLP or any of their affiliated entities or any employee or consultant with equivalent standing. Certain individuals, who are designated as partners, but who are not members of Hogan Lovells International LLP, do not hold qualifications equivalent to members. For more information about Hogan Lovells, the partners and their qualifications, see Where case studies are included, results achieved do not guarantee similar outcomes for other clients. Attorney Advertising. © Hogan Lovells All rights reserved. *Associated offices Hogan Lovells has offices in: Alicante Amsterdam Baltimore Beijing Brussels Budapest* Caracas Colorado Springs Denver Dubai Dusseldorf Frankfurt Hamburg Hanoi Ho Chi Minh City Hong Kong Houston Jakarta* Jeddah* Johannesburg London Los Angeles Luxembourg Madrid Miami Milan Moscow Munich New York Northern Virginia Paris Philadelphia Prague Rio de Janeiro Riyadh* Rome San Francisco São Paulo Shanghai Silicon Valley Singapore Tokyo Ulaanbaatar Warsaw Washington DC Zagreb*